6515--Oncology Reagents
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the VISN 22 Network Contracting Office, is conducting a Sources Sought / Request for Information (RFI) to identify potential sources for Oncology Reagents for the Greater Los Angeles VA Healthcare System. This RFI is for market research and planning purposes only and does not constitute a solicitation. Responses are due by May 1, 2026.
Scope of Work & Salient Characteristics
The VA is seeking oncology supplies and reagents that, at a minimum, meet the following specifications:
- Capable of detecting wild type (Negative) from Mutated (Positive) genes.
- Must test DNA extracted from whole blood or bone marrow samples using a reverse transcription-polymerase chain reaction (RT-PCR) based method or High-Resolution Melt (HRM) Analysis.
- Capable of determining DNA quantity by measuring optical density (OD) at 260 nm.
- Resultant DNA must be dilutable to a concentration of 5 ng/µl in 1x TE buffer at pH 8.0.
- Resultant DNA must be storable at +4 to +8°C for 1 week or at –20°C for longer term storage.
- Real-time (qPCR) reaction must be optimized for DNA samples containing 25 ng purified genomic DNA.
- The limit of detection (LOD) shall be 0.061%.
- Reagents must be storable at -15°C to -30°C.
- Minimum reagent shelf life of one year upon receipt.
- A specific brand mentioned for reference is the Ipsogen JAK2 MutaQuant Kit (Product # 673513), with a quantity of 77 kits (each containing 24 reagents).
Contract & Timeline
- Type: Sources Sought / Request for Information (RFI)
- Set-Aside: None specified (market research stage, seeking business size information)
- Response Due: May 1, 2026, at 3:00 P.M. Pacific Time
- Published: April 23, 2026
Submission Requirements
Interested and capable sources should provide:
- Company name, address, and point of contact.
- Business size status (e.g., SDVOSB, VOSB, HUBZone, WOSB, Large Business).
- Confirmation of small business status under NAICS 325413 (1250 Employees).
- Whether the company is a manufacturer or distributor, and the country of origin.
- If a distributor, details on any alteration, assembly, or modification of items.
- Information on existing federal contracts (GSA FSS, NAC, NASA SEWP, etc.) and if the referenced items are available.
- General pricing for market research purposes.
- Company DUNS number.
- Capabilities demonstrating that "equal to items" meet all required salient characteristics, with clear, compelling, and convincing evidence.
Important Notes
This RFI is for information and planning purposes only and does not constitute a solicitation. Responses are not offers and cannot form a binding contract. All expenses for responding are the responsibility of the responder. A future solicitation may be published, but responses to this RFI are not considered adequate for that. This notice is not a request to be added to a bidders list.